Xu B, Li W, Zhang Q, Shao Z, et al. Pertuzumab, trastuzumab, and docetaxel for Chinese patients with previously untreated HER2-positive locally recurrent or metastatic breast cancer (PUFFIN): a phase III, randomized, double-blind, placebo-controlled study. Breast Cancer Res Treat 2020 Jun 20. pii: 10.1007/s10549-020-05728.
PMID: 32564260